Exelixis
EXEL
#1761
Rank
NZ$19.48 B
Marketcap
NZ$72.38
Share price
-0.71%
Change (1 day)
20.58%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company